ALGS · Aligos Therapeutics, Inc.
$4.34
+0.09 (+2.00%)
At close · Jul 30
Going-concern doubt
— flagged May 7, 2026
Substantial doubt about the company's ability to continue as a going concern.
“our recurring losses from operations and negative cash flows have raised substantial doubt regarding our ability to continue as a going concern”View the 10-Q filed May 7, 2026
Market Cap
$15.25M
Shares
3.59M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
No Proposed Sales
No Form 144 proposed-sale notices are available for this stock yet.